Effects of lipoxin A4 on lipopolysaccharide induced proliferation and reactive oxygen species production in RAW264.7 macrophages through modulation of G-CSF secretion

Inflammation Research

Volumn 56, Issue 8, 2007, Pages 324-333

  Zhou, X Y ^a   Wu, P ^a   Zhang, L ^a   Xiong, W ^a   Li, Y S ^a   Feng, Y M ^a   Ye, D Y ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Eicosanoids; Inflammation; Inflammatory mediator; Lipopolysaccharide; Macrophages

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GRANULOCYTE COLONY STIMULATING FACTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXIN A; LUCIFERASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BACTERIAL OUTER MEMBRANE; CELL COUNT; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; INCUBATION TIME; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CELL PROLIFERATION; GRANULOCYTE COLONY-STIMULATING FACTOR; I-KAPPA B KINASE; LIPOPOLYSACCHARIDES; LIPOXINS; MACROPHAGES; MICE; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 34547751500     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7012-7     Document Type: Article

References (38)

1. Vulcano M, Meiss RP, Isturiz MA. Deferoxamine reduces tissue injury and lethality in LPS-treated mice. Int J Immunopharmacol 2000; 22: 635-44.
2. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005; 11: 3141-58.
3. Closa D, Folch-Puy E. Oxygen free radicals and the systemic inflammatory response. IUBMB Life 2004; 56: 185-91.
4. Wang W, Jittikanout S, Falk SA, Li P, Feng L, Gengaro PE et al. Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 2003; 284: F532-37.
5. Calkins CM, Barsness K, Bensard DD, Vasquez-Torres A, Raeburn CD, Meng X et al. Toll-like receptor-4 signaling mediates pulmonary neutrophil sequestration in response to gram-positive bacterial enterotoxin. J Surg Res 2002; 104:124-30.
6. Zhu QS, Xia L, Mills GB, Lowell CA, Touw IP, Corey SJ. G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood 2006; 107: 1847-56.
7. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins & Other Lipid Mediat 2002; 68269:433-55.
8. McMahon B, Mitchell S, Brady HR, Godson C. Lipoxins: revelations on resolution. Trends Pharmacol Sci 2001; 22:391-5.
9. Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004; 3: 401-16.
10. Chiang N, Fierro IM, Gronert K, Serhan CN. Activation of lipoxin A (4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 2000; 191: 1197-208.
11. Chiang N, Takano T, Arita M, Watanabe S, Serhan CN. A novel rat lipoxin A4 receptor that is conserved in structure and function. Br J Pharmacol 2003; 139: 89-98.
12. Sato Y, Kitasato H, Murakami Y, Hashimoto A, Endo H, Kondo H et al. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo. Biomed Pharmacother 2004;58:381-7.
13. Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, Serhan CN et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med 2006; 12: 330-4.
14. Chiang N, Arita M, Serhan CN. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids 2005; 73:163-77.
15. Nakazawa T, Morii H, Tamai M, Mori N. Selective upregulation of RB3/stathmin4 by ciliary neurotrophic factor following optic nerve axotomy. Brain Res 2005; 1061:97-106.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8.
17. Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of realtime PCR data. BMC Bioinformatics 2006; 7:85-97.
18. Lv T, Yao XX. Comparison of protocatechuic aldchyde in Radix Salvia miltiorrhiza and corresponding pharmacological sera from normal and fibrotic rats by high performance liquid chromatography. World J Gastroenterol 2006; 12:2195-200.
19. Zhang W, Wang Y, Chen CW, Xing K, Vivekanandan S, Lou MF. The positive feedback role of arachidonic acid in the platelet-derived growth factor-induced signaling in lens epithelial cells. Mol Vis 2006; 12: 821-31.
20. Bar-Yehuda S, Madi L, Barak D, Mittelman M, Ardon E, Ochaion A et al. Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents. Exp Hematol 2002; 30:1390-8.
21. Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B, Pestell RG. NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev 2001; 12:73-90.
22. Heasman SJ, Giles KM, Ward C, Rossi AG, Haslett C, Dransfield I. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J Endocrinol 2003; 178: 29-36.
23. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999;160:S5-11.
24. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000; 192: 3359-66
25. Gwinner W, Grone HJ. Role of reactive oxygen species in glomerulonephritis. Nephrol Dial Transplant 2000; 15: 1127-32.
26. Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. Journal of Leukocyte Biology 1992; 52: 269-73.
27. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002; 109:41-50.
28. Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 2002; 13: 2497-507.
29. Nicholson SE, Novak U, Ziegler SF, Layton JE. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood 1995; 86:3698-704.
30. Bashey A, Healy L, Marshall CJ. Proliferative but not nonproliferative responses to granulocyte colony-stimulating factor are associated with rapid activation of the p21RAS/MAP kinase signalling pathway. Blood 1994; 83:949-57.
31. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791-808.
32. Zhu QS, Xia L, Mills GB, Lowell CA, Touw IP, Corey SJ. G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood 2006; 107: 1847-56.
33. Rutella S, Zavala F, Danese S, Kared H, Leone G. Granulocyte Colony-Stimulating Factor: A Novel Mediator of T Cell Tolerance. J Immunol 2005; 175: 7085-91.
34. Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon DO. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 2005; 174: 8116-24.
35. Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kappaB: its role in health and disease. J Mol Med 2004; 82:434-48.
36. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 1999; 274: 27339-42.
37. Senftleben U, Karin M. The IKK/NF-kappa B pathway. Crit Care Med 2002; 30: S18-26.
38. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signaling. Semin Immunol 2000;12:85-98.